Health Condition 1: G409- Epilepsy, unspecified
Conditions
Interventions
Intervention1: Melatonin: Syrup or Tablet melatonin will be given to achieve sedation
Control Intervention1: Triclofos: Syrup will be given to achieve sedation
Sponsors
Bharati Hospital research Centre Pune
Eligibility
Inclusion criteria
Inclusion criteria: Al children coming for EEG who meet the age criteria
Exclusion criteria
Exclusion criteria: Children with acute illness, chronic heart disease, hepatic or renal disease, myopathy or had a prior complication on sedation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Number of EEG successfully completed 2. Sleep onset latency 3. Period of sleep 4. Incidence of adverse eventsTimepoint: 1. Number of EEG successfully completed at the end of procedure, usually half an hour 2. Sleep onset latency in minutes after onset of EEG procedure 3. Period of sleep in minutes, during and fater EEG 4. Incidence of adverse events within first 24 hours of drug administration | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Yield of epileptiform discharges on EEG 2. Need for second dose to achieve sedation 3. Artifacts in EEGTimepoint: Till successful completion of EEG | — |
Countries
India
Contacts
Public ContactSiddhant Lalwani
Bharati Vidyapeeth Deemed to be University Medical College, Pune
Outcome results
None listed